>
Flights Diverted as SpaceX Starship Self-Destructs Over Caribbean
Marco Rubio testifies at Senate hearing for secretary of state confirmation
Here's the confirmation hearing schedule for Trump's Cabinet picks
Do Not Consent to Health Tyranny
$200 gadget brings global satellite texting to any smartphone
New Study Confirms that Cancer Cells Ferment Glutamine
eVTOL 'flying motorcycle' promises 40 minutes of flight endurance
New Electric 'Donut Motor' Makes 856 HP but Weighs Just 88 Pounds
Physicists discover that 'impossible' particles could actually be real
Is the world ready for the transformational power of fusion?
Solar EV gets more slippery for production-intent Las Vegas debut
Hydrogen Finally Gets A Price Tag: S&P 500 New Energy Plays Soar Along With This Amazon Vendor
TSMC's New Arizona Fab! Apple Will Finally Make Advanced Chips In The U.S.
Study Reveals Key Alzheimer's Pathway - And Blocking It Reverses Symptoms in Mice
After the findings of the study were published, Australian Professor Ian Brighthope has classified the injections as class one carcinogens.
More than a year ago, Professor Dr. Angus Dalgleish, a renowned oncologist practising in the UK, first published his concerns that his patients with melanoma were relapsing after several years of being in remission.
"I could find none of the usual causes but on further investigation, I realised that they had all had a booster covid vaccine between three weeks and three months before their cancer's resurgence, the time in which their immune repression fails," he wrote in The Conservative Woman on Monday.
After raising the alarm that the vaccine boosters could induce cancer relapse, he became aware of literally dozens of people who had not had cancer before developing leukaemia and lymphomas after the boosters.
In November 2022, Prof. Dalgleish wrote an open letter to the editor-in-chief of the medical journal The BMJ, urging the journal that harmful effects of Covid injections be "aired and debated immediately" because cancers and other diseases are rapidly progressing among "boosted" people.
A few weeks later, he reported that other oncologists had contacted him to say they were seeing the same phenomenon of the recurrence of cancer in many melanoma patients who had been stable for long periods.